<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A67238CB-2373-4605-B999-E1499B873021"><gtr:id>A67238CB-2373-4605-B999-E1499B873021</gtr:id><gtr:name>Athersys Inc.</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/23BEE04F-45E4-4945-B5E3-7D21352F272F"><gtr:id>23BEE04F-45E4-4945-B5E3-7D21352F272F</gtr:id><gtr:name>Zoetis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4"><gtr:id>C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4</gtr:id><gtr:name>Genetech, Inc</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/453DB5AB-8BFE-4E0A-B761-1C39BD880D5D"><gtr:id>453DB5AB-8BFE-4E0A-B761-1C39BD880D5D</gtr:id><gtr:name>Scripps Research Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EF304075-C803-45F8-8F68-0CC2B0BE0135"><gtr:id>EF304075-C803-45F8-8F68-0CC2B0BE0135</gtr:id><gtr:name>Osaka University</gtr:name><gtr:address><gtr:line1>1-1 Yamadaoka Suita</gtr:line1><gtr:postCode>565 0871</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/AA7CF37A-1A3C-4DC6-8488-4445B285ACA2"><gtr:id>AA7CF37A-1A3C-4DC6-8488-4445B285ACA2</gtr:id><gtr:name>Genentech</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F25BC0C5-5284-441F-B79F-A61707946CA0"><gtr:id>F25BC0C5-5284-441F-B79F-A61707946CA0</gtr:id><gtr:name>University of California Los Angeles</gtr:name><gtr:address><gtr:line1>405 Hillgard Avenue</gtr:line1><gtr:line2>Box 951361</gtr:line2><gtr:postCode>90095</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Veterinary Medicine</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A67238CB-2373-4605-B999-E1499B873021"><gtr:id>A67238CB-2373-4605-B999-E1499B873021</gtr:id><gtr:name>Athersys Inc.</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1"><gtr:id>0A32DF0B-F2C5-42D5-A74A-32E1FD6B47D1</gtr:id><gtr:name>University of Massachusetts (UMass)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/23BEE04F-45E4-4945-B5E3-7D21352F272F"><gtr:id>23BEE04F-45E4-4945-B5E3-7D21352F272F</gtr:id><gtr:name>Zoetis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4"><gtr:id>C9FF1151-E064-4E1D-9054-B4BBF5A9E5D4</gtr:id><gtr:name>Genetech, Inc</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/453DB5AB-8BFE-4E0A-B761-1C39BD880D5D"><gtr:id>453DB5AB-8BFE-4E0A-B761-1C39BD880D5D</gtr:id><gtr:name>Scripps Research Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EF304075-C803-45F8-8F68-0CC2B0BE0135"><gtr:id>EF304075-C803-45F8-8F68-0CC2B0BE0135</gtr:id><gtr:name>Osaka University</gtr:name><gtr:address><gtr:line1>1-1 Yamadaoka Suita</gtr:line1><gtr:postCode>565 0871</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Japan</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AA7CF37A-1A3C-4DC6-8488-4445B285ACA2"><gtr:id>AA7CF37A-1A3C-4DC6-8488-4445B285ACA2</gtr:id><gtr:name>Genentech</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A9426E3-7F35-48FC-BD72-3776C8F90A4A"><gtr:id>4A9426E3-7F35-48FC-BD72-3776C8F90A4A</gtr:id><gtr:name>Grants Admin Office</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F25BC0C5-5284-441F-B79F-A61707946CA0"><gtr:id>F25BC0C5-5284-441F-B79F-A61707946CA0</gtr:id><gtr:name>University of California Los Angeles</gtr:name><gtr:address><gtr:line1>405 Hillgard Avenue</gtr:line1><gtr:line2>Box 951361</gtr:line2><gtr:postCode>90095</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/941C2E74-C576-49DA-9987-CE40EF8A611D"><gtr:id>941C2E74-C576-49DA-9987-CE40EF8A611D</gtr:id><gtr:name>Pfizer</gtr:name><gtr:address><gtr:line1>235 East 42nd Street</gtr:line1><gtr:postCode>10017</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1B9F6F30-BEEC-4C65-BAB7-78F6632A3AA3"><gtr:id>1B9F6F30-BEEC-4C65-BAB7-78F6632A3AA3</gtr:id><gtr:firstName>Clare</gtr:firstName><gtr:surname>Bryant</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0908953C-1190-4B93-8480-ED2A91D1A89D"><gtr:id>0908953C-1190-4B93-8480-ED2A91D1A89D</gtr:id><gtr:firstName>Duncan</gtr:firstName><gtr:surname>Maskell</gtr:surname><gtr:orcidId>0000-0002-5065-653X</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/BCA8A0AB-5B3A-4CF6-A412-D5BF12641AD6"><gtr:id>BCA8A0AB-5B3A-4CF6-A412-D5BF12641AD6</gtr:id><gtr:firstName>Laurence</gtr:firstName><gtr:otherNames>Stephen</gtr:otherNames><gtr:surname>Tiley</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6D889CF4-E3EC-432A-BEEE-7D2F056EFEBE"><gtr:id>6D889CF4-E3EC-432A-BEEE-7D2F056EFEBE</gtr:id><gtr:firstName>Thomas</gtr:firstName><gtr:otherNames>Peter</gtr:otherNames><gtr:surname>Monie</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER_COI</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FK006436%2F1"><gtr:id>FE306030-F233-45CF-A551-089B1F80DB19</gtr:id><gtr:title>Effects of Nod-like receptor activity on protective immunity against Salmonella infection</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/K006436/1</gtr:grantReference><gtr:abstractText>Infectious diseases remain major problems with significant economic and social impact despite the availability of antimicrobials and vaccines. The development of resistance to antimicrobials by microorganisms means that alternative control measures are required. Control of food-borne bacterial infections that infect people is particularly challenging because some bacteria can live in livestock without causing any harmful effects under the right circumstances (for example species of Salmonella enterica or Campylobacter in chickens) yet cause disease in humans. How this species-specific bacterial &amp;quot;tolerance&amp;quot; occurs is not understood which makes design of control strategies difficult. Vaccination strategies have reduced disease incidence for some bacteria, but many current vaccines are not ideal. Alternative approaches to combat infectious disease in livestock are to use selective breeding for disease resistance or to generate genetically modified animals to alter their susceptibility to infection. To design suitable control strategies it is essential to understand how bacteria co-exist with livestock.
Bacteria are recognised in humans and animals by specialised proteins called pattern recognition receptors (PRRs) to activate anti-bacterial immunity. There are major differences in the repertoires of PRRs and in the bacteria they detect between different species of mammals and birds. Our previous BBSRC funded research has found that some of the PRRs specifically the Nod Like Receptors (NLRs) NLRC4 and Nod2, that are missing from chickens, are important regulators of immune responses against Salmonella. Using comparative studies between mouse and chicken cells this grant will identify the NLR-signalling pathways driving the host response to infection. By expressing human NLRC4 or Nod2 in chicken cells and in chickens we will determine whether these PRRs contribute to why humans and animals react differently to the same salmonellae.</gtr:abstractText><gtr:technicalSummary>Infectious diseases remain major problems with significant economic and social impact despite the availability of antimicrobials and vaccines. The development of resistance to antimicrobials by microorganisms means that alternative control measures are required. Control of food-borne zoonotic bacterial infections is particularly challenging because some bacteria can behave like commensals in livestock under the right circumstances (for example Salmonella species) yet are pathogens in humans. The molecular basis for this species-specific bacterial &amp;quot;tolerance&amp;quot; is not understood which makes design of control strategies difficult. Vaccination strategies have reduced disease incidence for some bacteria, but many current vaccines have been generated empirically which often results in a product with limited efficacy. Alternative approaches to combat infectious disease in livestock are to use selective breeding for disease resistance traits or to generate genetically modified animals to alter their susceptibility to infection. To design suitable control strategies it is essential to determine how pathogens interface with host immunity

Pathogen recognition by host pattern recognition receptors (PRRs) activates innate and adaptive immunity. There are major differences in the repertoires of PRRs and in how they respond to ligands between different species of mammals and birds. The Nucleotide Oligomerisation Domain (Nod)-like receptors (NLRs) show wide species differences in repertoire with mice having 30, humans 22, and chickens 7. Our data show that the NLRs NLRC4 and Nod2 that are missing from chickens are important regulators of TH1 immunity against Salmonella infection. Using comparative studies between mouse and chicken cells this research will identify the NLR-signaling pathways driving the host response to infection. By expressing human NLRC4 or Nod2 in chickens we will determine whether these PRRs contribute to species-specific host responses to salmonellae.</gtr:technicalSummary><gtr:potentialImpactText>A central part of any strategy to reduce diseases such as salmonellosis must be intervention to induce the immune system to prevent infection or to clear infection rapidly. This is currently achieved by vaccination or immunotherapy. Alternative strategies include breeding animals for disease resistance traits or transgenic expression of genes to enhance bacterial clearance. To generate new vaccines, improve current vaccines or to pursue genetic modification we must understand the mechanisms by which immunity is induced, and this research will provide an essential element of that knowledge. 
Impact will be delivered to beneficiaries in the commercial private sector and in the wider public sector. This grant proposal is supported by an IPA agreement with Pfizer because the project will generate information that can be used to inform rational vaccine development against salmonellosis and potentially other bacterial pathogens (by 36 months). The grant is also likely to generate information as to which receptors are important for recognising salmonellae in species of commercial importance i.e. chickens (by 24 months). An added benefit of this grant is that the Nod-like receptors that are activated by salmonellae in mice are also conserved in humans: therefore this grant will generate data which may improve human vaccines against salmonellosis and will be of interest to the medical pharmaceutical industry (by 24 months). Development of improved vaccines and vaccine strategies will enhance UK economic competitiveness in animal and medical heath programs. The grant will have impact on the wider public sector by continuing our program of scientific communication. Our laboratories hosts up to 6 school children a year on work placements to engage them in the fundamentals of scientific research. Our research work is communicated in public forums such as the Cambridge science fair and during open days at the veterinary school. Dr Bryant is working closely with Dr Chris Smith of BBC Radio Cambridgeshire's Naked Scientists program to feature work on zoonotic diseases, with an emphasis on bacterial pathogens, and on multidisciplinary research (http://www.thenakedscientists.com/HTML/podcasts/show/2010.07.11/). The research in this grant will contribute to the zoonosis interest of the radio program and this should be realised within 24 months of starting the project. The grant will contribute to influencing policy decisions via Professor Maskell's membership of the General Advisory Committee on Science (GACS) at the Food Standards Agency and Dr Bryant's membership of the Veterinary Products Committee of the Veterinary Medicines Directorate. This project will develop new technical skills for the two postdoctoral researcher associates (PDRAs). Dr Tourlomousis will learn in vitro cell culture techniques to complement his skills in in vivo biology. The second, junior PDRA will use a range of skills including molecular techniques and in vitro cell culture skills and will receive training in these areas. Both PDRAs will learn imaging techniques through Dr Bryant's on-going collaboration with Dr Cicuta in Physics which forms part of her BBSRC Research Development fellowship. Both PDRAs will be involved in the public communication activities of this project. PDRAs will also attend BBSRC media training courses and University-run workshops on grant writing, communication skills and software training to develop their transferrable skills.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2013-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>744219</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Massachusetts Medical School</gtr:department><gtr:description>International and national collaborations with Kate Fitzgerald</gtr:description><gtr:id>409C3913-1E21-4758-B312-5AE33F1F5062</gtr:id><gtr:impact>Publications linked to our research grants have been facilitated by this collaboration.</gtr:impact><gtr:outcomeId>b95f3bceb95f3be2-1</gtr:outcomeId><gtr:partnerContribution>Provision of reagents, cell lines and intellectual input to our research.</gtr:partnerContribution><gtr:piContribution>Intellectual input and collaborative discussions about common research interests.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Osaka University</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>International and national collaboration with Shizuo Akira, Osaka University</gtr:description><gtr:id>361BDFAE-0F52-4C7B-8BAC-ED37DB52BDB1</gtr:id><gtr:outcomeId>b95f307ab95f308e-1</gtr:outcomeId><gtr:piContribution>Collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>1999-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Massachusetts Medical School</gtr:department><gtr:description>International and national collaboration with Eicke Laetz</gtr:description><gtr:id>F944D728-8F32-4229-AC00-DA992FB4100D</gtr:id><gtr:outcomeId>b95f36e2b95f36f6-1</gtr:outcomeId><gtr:piContribution>University of Massachusetts Medical School</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genentech</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>International Collaboration with Vishva Dixit</gtr:description><gtr:id>51AEB973-EDEA-437B-B10F-F6822FCA6F30</gtr:id><gtr:impact>No impact yet</gtr:impact><gtr:outcomeId>5448eee85ae196.98925922-1</gtr:outcomeId><gtr:partnerContribution>Provision of caspase knockout mice</gtr:partnerContribution><gtr:piContribution>Use of caspase knockout mice</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GSK Immunology Catalyst Sabbatical Award</gtr:description><gtr:id>6EC373F2-CF27-4012-B32A-3E10DF1447AE</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>58bea4f2263ab3.75559105-1</gtr:outcomeId><gtr:partnerContribution>GSK bought out my teaching and administration duties for 3 years and fund 2 postdoctoral researchers to work with me at GSK</gtr:partnerContribution><gtr:piContribution>GSK have bought out my teaching and administration duties for 3 years. I spend 3 days a week at GSK and have 2 postdoctoral researchers at GSK. I am working on inflammasome biology and Pattern Recognition Receptor research. I intellectually input into several of the GSK therapeutic units.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts (UMass)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>University of Massachusetts Medical School</gtr:department><gtr:description>Continued Collaboration with University of Massachusetts Medical Schoo</gtr:description><gtr:id>C809E79F-BA3F-4EF0-991E-B81650060AD7</gtr:id><gtr:impact>On going provision of reagents has enabled our publications for this grant.</gtr:impact><gtr:outcomeId>b960d6dcb960d6f0-1</gtr:outcomeId><gtr:partnerContribution>Provision of cell lines and reagents. Intellectual discussions about our research work.</gtr:partnerContribution><gtr:piContribution>Continuation of existing collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Trinity College Dublin</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Luke O'Neill, Trinity College, Dublin</gtr:description><gtr:id>9EEACB27-1F1D-49A4-A79D-08E7BF803C3D</gtr:id><gtr:impact>Publications</gtr:impact><gtr:outcomeId>b95f34eeb95f3502-1</gtr:outcomeId><gtr:partnerContribution>Intellectual input
Collaborative discussion
Transfer of new techniques</gtr:partnerContribution><gtr:piContribution>Collaboration with Trinity College, Dublin</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Scripps Research Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Bruce Beutler, The Scripps, USA</gtr:description><gtr:id>647806D9-13D7-4537-A943-CF020AE942B2</gtr:id><gtr:outcomeId>b95f33eab95f33fe-1</gtr:outcomeId><gtr:piContribution>Collaboration with The Scripps, USA</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2000-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Zoetis</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>International collaboration with Zoetis</gtr:description><gtr:id>3A45838F-A258-416F-A929-587CA9AA808D</gtr:id><gtr:impact>No impact yet</gtr:impact><gtr:outcomeId>544e4594444562.33789181-1</gtr:outcomeId><gtr:partnerContribution>Funding</gtr:partnerContribution><gtr:piContribution>Use of funds through research</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, Los Angeles (UCLA)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>International and national collaboration with David Underhill</gtr:description><gtr:id>AA2E82D6-24FF-45C9-9169-978568C4A9D6</gtr:id><gtr:outcomeId>b95f317eb95f3192-1</gtr:outcomeId><gtr:piContribution>Collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2000-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Athersys Inc.</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Respiratory, Inflammation and Autoimmunity</gtr:department><gtr:description>Astra Zeneca collaboration</gtr:description><gtr:id>D3AC33D9-9DDD-4B58-B28D-9067E0DD84AA</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>56b28531d95e67.93553830-1</gtr:outcomeId><gtr:partnerContribution>Provision of compounds and expertise</gtr:partnerContribution><gtr:piContribution>We are running a collaborative project with Cambridge Enterprise and AZ to look for novel drugs to treat allergic respiratory disease. We perform the functional biology</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Genetech, Inc</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Genentech Visiting Professorship</gtr:description><gtr:id>7F47D4CD-A64C-4C30-BCEF-94585DE72A02</gtr:id><gtr:impact>None yet as the work is still in progress</gtr:impact><gtr:outcomeId>58bea1c5e94e86.75233010-1</gtr:outcomeId><gtr:partnerContribution>My collaborators gave me novel reagents and supported my research during my time in the USA</gtr:partnerContribution><gtr:piContribution>I visited Genentech South San Francisco site and performed research in the laboratory there for 9 months. Two of my PhD students also had 3 month internships working with myself and my Genentech collaborators. We learnt new techniques and gained access to new reagents. I intellectually contributed to their inflammasome research program.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Co-chair Antibiotic Resistance Forum at the Cambridge Science Fair</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>27048305-5F00-466F-8826-03936B5FEC94</gtr:id><gtr:impact>I organised, spoke at and co-chaired a debate session on anti-bacterial resistance at the Cambridge Science Fair. This provoked considerable debate and discussion with members of the general public, school children and academic attendees.</gtr:impact><gtr:outcomeId>56c27490abdbc4.79256207</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://soundcloud.com/university-of-cambridge/17-march-2015-preventing-the-rise-of-antibiotic-resistance</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio Cambridgeshire Interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E6907CD1-A5F0-498A-9B69-5066F6650A08</gtr:id><gtr:impact>Radio interview to explain why ARUK had given me a discipline hopping grant. My interview discussed how immunology impacts on Alzheimer's disease and how our research might help generate new therapeutic approaches to a lay audience.

None as yet</gtr:impact><gtr:outcomeId>5638d157bd76b7.72958109</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hill Rd Comprehensive School: The Immune System: Your Inner Army</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>2AFE1B2E-75ED-4A41-AD21-E5C8A3068AE6</gtr:id><gtr:impact>Invited talk to pupils

No notable impact to date</gtr:impact><gtr:outcomeId>544e56d08b5fe8.42349705</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Queens College Academic Saturday 2014: Why cats make you sneeze</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>79F5926C-5AA6-4D40-AFA0-12E42F13CCC8</gtr:id><gtr:impact>Public engagement

No notable impact yet</gtr:impact><gtr:outcomeId>544e5463eec0a3.45785018</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:url>http://www.queens.cam.ac.uk/life-at-queens/news-and-events/academic-saturday-11th-october</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poultry Vet CPD Course</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F4C978EC-99AD-4870-AE46-D307833346F5</gtr:id><gtr:impact>I gave a talk about how chickens detect Salmonella, why this might contribute to its zoonotic potential and how our research may allow us to develop therapeutic strategies. This talk was given to poultry vets, poultry breeders and representatives from poultry processing companies. About 100 stakeholders attended this event in Belfast. This generated considerable discussion about preventative strategies not only for Salmonella infections but also for other food based bacterial infections.</gtr:impact><gtr:outcomeId>56c272324d1364.25774111</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cheltenham Science Festival 2014: The Immune System: Your Inner Army</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>9364AE3F-99F6-40BC-B220-6B6B67FE08E2</gtr:id><gtr:impact>Public engagement

No notable impacts to date</gtr:impact><gtr:outcomeId>544e5666cc70f5.27936578</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cheltenhamfestivals.com/science/whats-on/2014/the-immune-system-your-inner-army/</gtr:url><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EMBO Innate Immunity Course South Africa: Lecturer</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>69182958-717B-419B-AED5-7D0F3E80A032</gtr:id><gtr:impact>EMBO ran a course for postgraduate students and other scientists in S Africa particularly aimed at informing them about new ways to develop their research into infectious disease.</gtr:impact><gtr:outcomeId>56b5382ae17d87.68453173</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Bacterial recognition by PRRs</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D5B38902-B8C6-4440-8DEC-9948B24EFF6F</gtr:id><gtr:impact>Toll2011, Garda, Italy: &amp;quot;Bacterial recognition by PRRs&amp;quot;

no actual impacts realised to date</gtr:impact><gtr:outcomeId>r-5943624308.2802960ce3ccdc</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research or patient groups</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lafferty Debate participant</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C5B4B374-210E-4D9E-8031-BA76F6D4EDB0</gtr:id><gtr:impact>Participated in a public debate on &amp;quot;Adaptive Immunity is innately redundant&amp;quot;</gtr:impact><gtr:outcomeId>58bebfd38e8595.88528426</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Presentation on Antimicrobial Resistance to the Cambridge Enterprise network</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>986B6767-0C95-4833-810A-5B2DE88581AB</gtr:id><gtr:impact>I gave a presentation to a group of Cambridge Entrepreneurs about anti-microbial resistance and the challenges we faced to over come it. The talk generated a large number of questions.</gtr:impact><gtr:outcomeId>56c2751b006645.56834662</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Industry/Business</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>2200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Senior Investigator Award</gtr:department><gtr:description>Wellcome Trust Investigator Award</gtr:description><gtr:end>2021-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>EECD799B-A794-4BEE-BDE3-7ACFC4C7881F</gtr:id><gtr:outcomeId>56b28923cd5dd9.84179062</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>226000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Elion and Black Immunology Catalyst Sabbatical Award</gtr:description><gtr:end>2019-10-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>31C692D9-FDDF-44A7-AAF6-A3DB2355AFB2</gtr:id><gtr:outcomeId>56c3aee548a740.84843292</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>267000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Royal Society Wolfson Refurbishment Scheme</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>ED3A9CF8-6471-4D6D-A480-3CB3CE8C2567</gtr:id><gtr:outcomeId>56b289997518d2.05135438</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>204000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Interdisciplinary Research Grant</gtr:description><gtr:end>2018-01-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:fundingRef>ARUK-IRG2014-13</gtr:fundingRef><gtr:id>5B7A77DB-9413-4E50-B38D-FF5AFD0F35EA</gtr:id><gtr:outcomeId>545798555e4953.51071796</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-02-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>Our fundings have been disseminated to a number of different groups of stakeholders and the general public. For example in 2015 our work on poultry immunology was delivered to the Poultry Conference in Belfast to poultry veterinary surgeons, poultry breeders and other stakeholders in January 2015. I also co-hosted an antimicrobial resistance fora to the general public at the Cambridge Science Fair (March 2015) and I gave a talk on the impact of antimicrobial resistance to the Cambridge Enterprise network (a group of Cambridge entrepreneurs) in November. I have also talked about our work at GSK which has led to significant collaborative funding.</gtr:description><gtr:firstYearOfImpact>2015</gtr:firstYearOfImpact><gtr:id>CBD1726A-7C4C-412A-A4C5-399E44E57BA9</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>545793a7934494.22164704</gtr:outcomeId><gtr:sector>Communities and Social Services/Policy,Education,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>In this grant we have determined how Salmonella is recognised in the host through specialised receptors called Pattern Recognition Receptors (PRRs). We have shown how PRRs control Salmonella infections in animals. We have also shown that the protective immune response against this bacterium is influenced by PRRs. The protective immune response is the mechanism by which vaccines work and our data will be useful in designing anti-salmonella vaccines. We have found that critical members of the PRRs which recognise Salmonella are missing in chickens. We have identified that the chicken has some compensatory mechanisms to detect Salmonella, but is, overall, less able to detect this bacterium.</gtr:description><gtr:exploitationPathways>Optimisation of anti-Salmonella vaccination strategies in humans and poultry.
Guidance as to the provision of the best adjuvant to enhance vaccine efficacy against Salmonella in humans and poultry.
Guidance on potential disease resistance traits for poultry breeders.
Fundamental information on the innate and adaptive response against Salmonella in humans and poultry for the scientific community.</gtr:exploitationPathways><gtr:id>49B6AF08-C2C2-40C8-89F4-6CEC55ECA56F</gtr:id><gtr:outcomeId>54579450b2e4f9.67695220</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Communities and Social Services/Policy,Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>DB5D42B6-4471-4551-B5F0-DC82261137AF</gtr:id><gtr:title>International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease.</gtr:title><gtr:parentPublicationTitle>Pharmacological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc38ddc2aa13707bc8b3e3c7d2d3829c"><gtr:id>dc38ddc2aa13707bc8b3e3c7d2d3829c</gtr:id><gtr:otherNames>Bryant CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0031-6997</gtr:issn><gtr:outcomeId>56b28243c1ed49.04021321</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA32A641-3130-4268-A7BC-85274CAF19FA</gtr:id><gtr:title>Energetics of Endotoxin Recognition in the Toll-Like Receptor 4 Innate Immune Response.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/770c2fe5cc77733e7ef1ee520d315165"><gtr:id>770c2fe5cc77733e7ef1ee520d315165</gtr:id><gtr:otherNames>Paramo T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56b26768843cf0.34319532</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D4150C5-6A92-4DD0-9C8A-A1E420BCC15C</gtr:id><gtr:title>Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome.</gtr:title><gtr:parentPublicationTitle>Microbiome</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/48a6374f1846c920ceb29c32198b1dad"><gtr:id>48a6374f1846c920ceb29c32198b1dad</gtr:id><gtr:otherNames>Falcone EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2049-2618</gtr:issn><gtr:outcomeId>58af2b7a0ad178.33250313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91EAEF39-5A1F-4A04-A04B-5A778F7FB0A6</gtr:id><gtr:title>Actin polymerization as a key innate immune effector mechanism to control Salmonella infection.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/233be6778cd6f4d7cdaf183640ad78de"><gtr:id>233be6778cd6f4d7cdaf183640ad78de</gtr:id><gtr:otherNames>Man SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5675dd0d71fab</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB7E9F5E-E84C-4BDE-807D-D482DE7A758D</gtr:id><gtr:title>Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages.</gtr:title><gtr:parentPublicationTitle>Cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0911bfc22cf8becbc426a0ccadc52d0"><gtr:id>c0911bfc22cf8becbc426a0ccadc52d0</gtr:id><gtr:otherNames>Mills EL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0092-8674</gtr:issn><gtr:outcomeId>58af2b31620e67.88617405</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06CCB6D2-AFD8-41EA-8B75-9F852C09DCFD</gtr:id><gtr:title>Caspase-8 functions as a key mediator of inflammation and pro-IL-1&amp;Icirc;&amp;sup2; processing via both canonical and non-canonical pathways.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2bdbcc6c899882f237eac5d622f63da8"><gtr:id>2bdbcc6c899882f237eac5d622f63da8</gtr:id><gtr:otherNames>Monie TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>5675e2814033a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2B9AA239-C703-41DA-B48F-19B675728483</gtr:id><gtr:title>Inflammasome activation causes dual recruitment of NLRC4 and NLRP3 to the same macromolecular complex.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/233be6778cd6f4d7cdaf183640ad78de"><gtr:id>233be6778cd6f4d7cdaf183640ad78de</gtr:id><gtr:otherNames>Man SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>doi_55f94b94bf831951</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69294999-7D94-4587-AA17-BA43380367F7</gtr:id><gtr:title>Toll-like receptor signalling through macromolecular protein complexes.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc38ddc2aa13707bc8b3e3c7d2d3829c"><gtr:id>dc38ddc2aa13707bc8b3e3c7d2d3829c</gtr:id><gtr:otherNames>Bryant CE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn><gtr:outcomeId>56b28244323ca9.09903508</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11BC159C-E9A8-47E7-BD11-F1F67B1B3609</gtr:id><gtr:title>The TLR4 D299G and T399I SNPs are constitutively active to up-regulate expression of Trif-dependent genes.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb780308ed4b3a47b85d3c436b014ea0"><gtr:id>bb780308ed4b3a47b85d3c436b014ea0</gtr:id><gtr:otherNames>Hold GL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56b28243325644.64181516</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D290705B-DF76-446D-9FB5-0DE970487D4E</gtr:id><gtr:title>CARD9 negatively regulates NLRP3-induced IL-1? production on Salmonella infection of macrophages.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d6655093a5bc86957efe50b469eaf7b"><gtr:id>4d6655093a5bc86957efe50b469eaf7b</gtr:id><gtr:otherNames>Pereira M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>588b22395a4d42.57988099</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A7B3015-63EC-4796-9571-34D8FA1931FF</gtr:id><gtr:title>Innate immunity. A Spaetzle-like role for nerve growth factor ? in vertebrate immunity to Staphylococcus aureus.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e00e1f5774e5f011450777d3b80e36c"><gtr:id>5e00e1f5774e5f011450777d3b80e36c</gtr:id><gtr:otherNames>Hepburn L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>56b2824359db89.31492578</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03A2D6CF-F2B3-4228-9869-2604E080ECB1</gtr:id><gtr:title>Assembly and localization of Toll-like receptor signalling complexes.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a7af28f06edb07f35fdd2d1d85b73704"><gtr:id>a7af28f06edb07f35fdd2d1d85b73704</gtr:id><gtr:otherNames>Gay NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-1733</gtr:issn><gtr:outcomeId>56b28242eac8a4.54474036</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A207185B-2D75-4150-B573-E9085A19616B</gtr:id><gtr:title>Mitochondrial damage contributes to Pseudomonas aeruginosa activation of the inflammasome and is downregulated by autophagy.</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f9aff1e6f2b2a8802edd784a88b8c8"><gtr:id>72f9aff1e6f2b2a8802edd784a88b8c8</gtr:id><gtr:otherNames>Jabir MS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn><gtr:outcomeId>56b28243edbf27.55809976</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B4F9808-E640-4C67-9406-127AB3CED277</gtr:id><gtr:title>Salmonella infection induces recruitment of Caspase-8 to the inflammasome to modulate IL-1? production.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/233be6778cd6f4d7cdaf183640ad78de"><gtr:id>233be6778cd6f4d7cdaf183640ad78de</gtr:id><gtr:otherNames>Man SM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>544531ab31eec1.34420211</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD8A6B6E-D3B7-4723-BC39-9A9782720F2D</gtr:id><gtr:title>Mitogen-activated protein kinases (MAPKs) are modulated during Francisella tularensis infection, but inhibition of extracellular-signal-regulated kinases (ERKs) is of limited therapeutic benefit.</gtr:title><gtr:parentPublicationTitle>European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/07c482173eb01a10263e8f9383b9cc27"><gtr:id>07c482173eb01a10263e8f9383b9cc27</gtr:id><gtr:otherNames>Saint RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0934-9723</gtr:issn><gtr:outcomeId>58af2ae209a588.31407263</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>537BCC87-A22B-414F-AB4B-0184C726E882</gtr:id><gtr:title>Lipopolysaccharide-induced NF-?B nuclear translocation is primarily dependent on MyD88, but TNFa expression requires TRIF and MyD88.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/982db68136bc0805ca8cca9fac8a1822"><gtr:id>982db68136bc0805ca8cca9fac8a1822</gtr:id><gtr:otherNames>Sakai J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a9043526b30b2.50615221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D921A55-9C7E-444E-86A2-5BFD7D038077</gtr:id><gtr:title>IL-27 Induced by Select Candida spp. via TLR7/NOD2 Signaling and IFN-&amp;Icirc;&amp;sup2; Production Inhibits Fungal Clearance.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e7a80fbfe5c4e7ecd2680d38340decd"><gtr:id>9e7a80fbfe5c4e7ecd2680d38340decd</gtr:id><gtr:otherNames>Patin EC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>585d40c93ea9d9.59496145</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC53F0CE-EDCB-429A-BC7C-60B7499CC6A2</gtr:id><gtr:title>The frequency and duration of Salmonella-macrophage adhesion events determines infection efficiency.</gtr:title><gtr:parentPublicationTitle>Philosophical transactions of the Royal Society of London. Series B, Biological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/89ccc0f8d470f7b083907c99fa22118d"><gtr:id>89ccc0f8d470f7b083907c99fa22118d</gtr:id><gtr:otherNames>Achouri S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0962-8436</gtr:issn><gtr:outcomeId>doi_55f94d94d299f0f8</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/K006436/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>48D25546-6ADF-479A-8877-478CCDB1DC1F</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal Science</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>A442BF36-F335-483E-9282-F3BB48AC2C47</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Cell biology</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>455F5D87-6317-4EF0-9D74-72B5D9BD6375</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Food science &amp; nutrition</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>A502D25A-BB70-4F74-844D-32A2BAD075A5</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal Diseases</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>9CAF586D-4FCC-4763-929E-82834270D8B0</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Food microbiology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>E2AC43A0-F15F-4F00-8557-FB2D01D65940</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Immunology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>B76F0E6B-0363-4D1F-9F5F-353AFD4E9DB0</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Livestock production</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>DDA3AC5B-B4B5-4323-988E-62B85A8966BF</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Receptors</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>